CopyMark Law Group
4.9/5
Drawing for ONCOS

USPTO serial 77934112

ONCOS

Reviewed by CopyMark Law Group

Reg. 3936524Status 710
Filing date
Status date
Registration date
Mar 29, 2011
Examiner
WHITTAKER BROWN, TRACY
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ONCOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yuval H. Marcus

Yuval H. Marcus Leason Ellis LLPOne Barker Avenue, Fifth FloorWhite Plains, NY 10601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations [ ; pharmaceutical agents in the form of tablets, capsules and powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biopharmaceutical agents in the form of oncolytic viruses that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ] all for the prevention and treatment of human diseases in the field of oncologySECTION 8 - CANCELLED—
042[ Scientific and pharmaceutical research, namely, developing therapies based on oncolytic viruses for use in treatment of human diseases in the field of oncology ]SECTION 8 - CANCELLED—
044[ Medical, and health care services; pharmaceutical care services, namely, dispensing pharmaceuticals; medical advisory, consultancy and information services all relating to cancer therapies based on oncolytic viruses ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 29, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 3, 2017NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Nov 3, 20178.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Oct 24, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 27, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 25, 2017ES8RTEAS SECTION 8 RECEIVED—
Mar 29, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 3, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 29, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 11, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 11, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 1, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Nov 29, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 29, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 29, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 29, 2010ZZBXALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION—
Nov 29, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2010ALIEASSIGNED TO LIE—
Nov 9, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2010DOCKASSIGNED TO EXAMINER—
Feb 18, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance